| Cash Flow for Alexion Pharmaceuticals Inc. (ALXN) | | | | After Hours: $ 30.14 |  -0.86 (-2.77%) | Volume: 9.99 k | 6:03 PM EST Nov 21, 2008 | | | | | | | Cash Flow | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 07/2005 | 07/2004 | | | Net Income | (92,290) | (131,514) | (57,956) | (108,750) | (74,095) | | Depreciation & Amortization | 4,927 | 3,706 | 1,636 | 3,682 | 3,593 | | Deferred Income Taxes | - | - | - | - | - | | Operating Losses | 542 | 141 | 4,314 | (2,217) | 866 | | Extraordinary Losses | - | - | - | - | - | | | Decrease in Receivables | (49,545) | - | - | - | (3,767) | | Decrease in Inventories | (30,593) | (2,314) | - | - | - | | Decrease in Other Current Assets | - | - | - | - | 1,363 | | Increase in Payables | 11,478 | 7,074 | (3,589) | 3,482 | (412) | | Increase in Other Current Liabilities | - | (4,401) | 3,967 | 3,945 | 524 | | Decrease in Other Working Capital | (5,343) | (4,702) | - | - | - | | Other Non-Cash Items | 21,650 | 21,154 | - | - | - | | Net Cash from Continuing Operations | (139,614) | (109,914) | (50,365) | (96,883) | (71,993) | | Net Cash from Discontinued Operations | - | - | - | - | - | | Cash from Operating Activities | (139,614) | (109,914) | (50,365) | (96,883) | (71,993) | | | | Sale of Property, Plant, Equipment | - | - | - | - | - | | Sale of Short Term Investments | 87,985 | 853,924 | 398,971 | 513,423 | 205,242 | | | Purchase of Property, Plant, Equipment | (68,825) | (31,856) | (444) | (2,980) | (3,135) | | Acquisitions | - | - | - | - | - | | Purchase of Short Term Investments | (48,719) | (734,567) | (419,086) | (508,818) | (168,952) | | Other Investment Changes, Net | 32,636 | (33,594) | - | - | (5) | | Cash from Investing Activities | 3,077 | 53,907 | (20,559) | 1,625 | 33,150 | | | Issuance of Debt | 18,000 | 26,000 | - | 150,000 | - | | Issuance of Capital Stock | 47,005 | 153,827 | 67,991 | 3,743 | 127,223 | | | Repayment of Debt | (161) | (224) | - | (120,000) | - | | Repurchase of Capital Stock | - | (279) | (381) | - | - | | Payment of Cash Dividends | - | - | - | - | - | | Other Financing Charges, Net | - | - | - | (4,758) | - | | Cash from Financing Activities | 64,844 | 179,324 | 67,610 | 28,985 | 127,223 | | | | Effect of Exchange Rate Changes | 188 | (120) | (8) | - | - | | Net Change in Cash | (71,505) | 123,197 | (3,322) | (66,273) | 88,380 | | | Cash at Beginning of Year | 166,826 | 43,629 | 46,951 | 113,224 | 24,844 | | Cash at End of Period | 95,321 | 166,826 | 43,629 | 46,951 | 113,224 | | | |
